The delay in diagnosis changes the prognosis, treatment approach, and the cost associated with it, dramatically
By Jame Abraham, M.D, FACP, Cleveland Clinic
Arathi is a 47-year-old, highly successful systems engineer from Mumbai. About six months ago, she noticed some discomfort in her left breast. When she raised her arm above her head to comb her hair, she noticed some skin changes on the left breast. But she chose to ignore that, too. When she developed a constant nagging pain in her…

This new class of drugs unleashes the body's immune system to fight tumors. This seems to solve a century-old mystery of how cancerous cells manage to evade the body's immune system. The drug which Merck will sell under the name of Keytruda was approved by patients with advanced melanoma who have exhausted other therapies.
Changed
08/Sep/2014
Community
Condition